Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperprolactinemia. Causes, consequences, and treatment options

T B Kaye1

  • 1Section of Endocrinology, Diabetes and Metabolism, Lahey Hitchcock Medical Center, Burlington, MA 01805, USA.

Postgraduate Medicine
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypercalcemia due to subacute thyroiditis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2004
Same author

Effect of an inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis).

Journal of internal medicine·1999
Same author

Triple oral antidiabetic therapy.

Journal of diabetes and its complications·1999
Same author

Promoting cost-saving generics.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1996
Same author

PTHrP-mediated hypercalcemia in a calcitonin-producing islet cell tumor.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·1995
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
Same journal

Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

Postgraduate medicine·2026
Same journal

Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

Postgraduate medicine·2026
Same journal

Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

Postgraduate medicine·2026
Same journal

The prevalence of functional iron deficiency and its impact on mortality in patients receiving hemodialysis.

Postgraduate medicine·2026
See all related articles

Hyperprolactinemia, a common pituitary issue, is often caused by tumors or medications. Diagnosis involves history, exams, lab tests, and imaging, guiding tailored treatment plans.

Area of Science:

  • Endocrinology
  • Neuroendocrinology
  • Pituitary Disorders

Background:

  • Hyperprolactinemia is a frequent endocrine disorder stemming from the pituitary gland.
  • Elevated prolactin levels can arise from various physiological and pathological conditions.

Purpose of the Study:

  • To outline the diagnostic approach for hyperprolactinemia.
  • To identify common etiologies and emphasize tailored treatment strategies.

Main Methods:

  • Clinical history review.
  • Physical examination.
  • Laboratory testing (including prolactin levels).
  • Magnetic resonance imaging (MRI) of the sella turcica when indicated.

Main Results:

Related Experiment Videos

  • Pituitary tumors and medications are the most frequent causes of hyperprolactinemia.
  • Diagnostic workup effectively identifies the underlying cause in most cases.

    • Conclusions:

    • Hyperprolactinemia diagnosis relies on a combination of clinical assessment and targeted investigations.
    • Treatment of hyperprolactinemia should be individualized based on the etiology and patient factors.